MedPath
FDA Approval

Tranexamic Acid

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Apotex Corp.
DUNS: 845263701
Effective Date
December 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tranexamic acid(100 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Apotex Inc.

209429182

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tranexamic Acid

Product Details

NDC Product Code
60505-6169
Application Number
ANDA209860
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
December 5, 2023
Code: 6T84R30KC1Class: ACTIBQuantity: 100 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath